DATAPHARM A/S: Financial statements 2024
CVR: 72323211
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK 650,613 compared with DKK 703,717 the year before. Equity in the 2024 report amounted to DKK 11,092,867. The solvency ratio was 77.6%.
- Profit/Loss
- DKK 650,613
- Equity
- DKK 11,092,867
- Total Assets
- DKK 14,295,027
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | 651 t. | 11.1 mio. | 0 |
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
DATAPHARM A/S has published its annual report for 2023. The net result was DKK 703,717.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.